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signiﬁcantly affecting prognosis in systemic sclerosis.
Aim of work: Microalbuminuria detection in SSc patients as an indicator of early renal involve-
ment and its correlation with various SSc clinical, laboratory parameters and severity of organ sys-
tems’ damage assessed by Scleroderma Assessment Questionnaire.
Patients and methods: Forty SSc patients (33 females and 7 males) with mean age of
27.48 ± 12.56 years and mean disease duration of 6.2 ± 4.14 years were included. Twenty-four
(60%) had lSSc; 13 (32.5%) had dSSc and 3 (7.5%) patients had SSc sine scleroderma.
Results: Eight (20%) hadmicroalbuminuria and 9 (22.5%) patients had decreased creatinine clear-
ance. Albumin/creatinine ratio was signiﬁcantly higher among dSSc patients compared to those with
lSSc and SSc sine scleroderma (X2 = 9.077; p= 0.01). Albumin/creatinine ratio showed signiﬁcant
positive correlations with telangiectasia (r= 0.322; p= 0.04) and mRodnan’s skin score549170626.
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20 S.A. Hussien et al.(r= 0.352; p= 0.026) and negative correlations with inter-incisor distance (r= 0.525; p= 0.001)
and pleurisy (r= 0.446; p= 0.004).Albumin/creatinine ratio correlated signiﬁcantly and positively
with IMSS and IDS indices of SAQ (r= 0.378, 0.32; p= 0.016, 0.044, respectively). SSc patients with
microalbuminuria showed signiﬁcantly higher mean IDS than those without (1.058 vs. 0.631,
p= 0.04). No statistically signiﬁcant correlations were found between creatinine clearance and the
different demographic, clinical features and the indices of SAQ.
Conclusion: Microalbuminuria compared to creatinine clearancemay be amore sensitive indicator
of early renal affection and predictor of increased morbidity.
 2011 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Systemic sclerosis (SSc) is a generalized disorder of connective
tissue which is characterized by thickening and ﬁbrosis of the
skin and by distinctive forms of involvement of internal
organs; notably the heart, lungs, kidneys and gastrointestinal
tract [1].
Renal involvement and systemic vascular damage have
been shown to be signiﬁcantly affecting prognosis in SSc. Sur-
vival rates of patients with SSc are critically dependent on the
presence and severity of renal involvement. Different types of
kidney disease have been described [2].
An increased excretion of total urinary protein is a classical
hallmark of renal diseases. Assay of total urinary protein is
non-speciﬁc and insensitive and the advent of sensitive and
speciﬁc assay for albumin, the dominant urinary protein in
patients with renal glomerular dysfunction, has enabled the
detection of abnormalities at an earlier stage of the disease
process [3].
It is often difﬁcult to assess damage to the renal and systemic
vasculature in SSc patients. Using detailed urinary protein anal-
ysis is thought to detect scleroderma renal disease at an early
stage and to assess systemic vasculopathy. Abnormal urinary
protein excretion is associated with parameters of increased
morbidity such as diffuse cutaneous disease and visceral
involvement. Systemic sclerosis patients with microalbuminuria
have a worse prognosis than those with normal renal function
[4]. Normal urinary protein excretion is up to 150 mg/day.
Microalbuminuria refers to the excretion of a very small amount
of proteins, primarily composed of albumin that could not be
detected by routine methods, i.e., dip stick method [5]. Accord-
ing to the American Diabetes Association, microalbuminuria is
deﬁned as urinary albumin excretion (UAE) of 30–299 mg/ 24 h
or albumin/creatinine ratio of 30–299 lg/mg creatinine [6].
In SSc, the inﬂammatory process is very mild and organ
damage develops often insidiously and slowly. Mostly used
diagnostic procedures are not sensitive enough to detect organ
damage in the early phase and to notice the minimal change in
damage or function over time. Symptoms and subjective
patient’s complaints are very important in the evaluation of
disease status in SSc. Scleroderma Assessment Questionnaire
(SAQ) demonstrates the severity of damage of the different
organ systems and the degree of change in the severity of affec-
tion over time [7].
The objective is microalbuminuria detection in SSc patients
and its evaluation as an indicator of early renal involvement
and to ﬁnd out its correlation with the various SSc clinical,
laboratory, radiological disease parameters and severity of or-
gan systems’ damage assessed by SAQ.2. Patients and methods
2.1. Study population
Forty SSc patients (33 females and 7 males) with a mean age
of 27.48 ± 12.56 years and mean disease duration of
6.2 ± 4.14 years, fulﬁlling SSc criteria described by The Sub-
committee for Scleroderma Criteria of the American College
of Rheumatology [8], attending the Rheumatology and Reha-
bilitation Department, Kasr El-Aini Hospitals, Cairo Univer-
sity, comprised the study group.
 SSc patients were subdivided according to the classiﬁcation
subsets of SSc patients, which is based on the extent of skin
affection. Twenty-four (60%) had limited SSc; 13 (32.5%)
had diffuse SSc [9] and 3 (7.5%) patients had SSc sine
scleroderma [10].
 Exclusion criteria: Localized forms of scleroderma, various
forms of pseudo-scleroderma, SSc patients with associated
arterial hypertension, diabetes mellitus, cardiovascular dis-
eases including pulmonary hypertension, heart failure, pre-
existing renal disease (e.g., renal agenesis or polycystic
kidney disease), urinary tract infection and hematuria.
Other conditions that may invalidate urine albumin excre-
tion, e.g., exercise within 24 h, acute febrile illness and
pregnancy.
All patients included in the study were subjected to:
(A) Full history taking including Scleroderma Assessment
Questionnaire (SAQ) [11].
 SAQ consists of 23 questions divided into 4
subgroups: 4 items related to vascular, 6 items to
respiratory, 5 items to gastrointestinal and 8 items
to musculoskeletal dysfunctions. Some items are
derived from the Systemic Sclerosis Questionnaire
(SySQ), with permission of the authors. The range
of all indices is from 0 to 3. Answering categories:
(A) intensity of symptoms (no = 0, some = 1, mod-
erate =2, very intensive = 3), (B) frequency of
symptoms (never = 0, sometimes = 1, fre-
quently = 2, always =3) and (C) ability to perform
activities (without difﬁculty = 0, with some difﬁ-
culty = 1, with much difﬁculty = 2, not able to
do = 3). The Index of Vascular Status (IVS), Index
of Respiratory Status (IRS), Index of Gastrointesti-
nal Status (IGS) and Index of Musculoskeletal Status
(IMSS) are calculated by dividing the total score for
a particular group by the number of questions for
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severe damage of a particular organ system. By
dividing the total score for the entire questionnaire
by the number of questions, the Index of Disease Sta-
tus (IDS) was obtained.
(B) Thorough general (including interincisor and ﬁnger to
palm (in ﬂexion) distances in cm [12], cardiopulmonary,
abdominal, musculoskeletal and neurological system
examinations.
(C) Skin examination including calcinosis, digital lesions
and assessment of skin sclerosis severity by modiﬁed
Rodnan’s skin score (mRss) [13].
(D) Vascular system examination including Raynaud’s phe-
nomenon, digital pitting scar, digital gangrene and bone
resorption.
(E) Laboratory investigations:
 Complete blood picture was done by Cell Dyne 1800.
ESR was done by Westergren technique.
 Liver enzymes (AST, n: 0–41 U/L and ALT, n: 0–41
U/L).
 Kidney functions: serum Creatinine (n: 0.32–1.2 mg/
dl).
 Muscle enzymes (CPK, n: 0–195 U/L and LDH, n:
240–480 U/L).
– All chemical analysis of blood and creatinine in
urine were done on Hitachi 917 by a kit purchased
from Roche Diagnostic GmbH, D-68298
Mannheim.
 ANAs: positivity and pattern were identiﬁed by indi-
rect immunoﬂuorescence (IIF).
 Urinalysis
– Complete urine analysis (physical appearance,
chemical constitutes and microscopic contents).
– 24 h urinary protein (n: up to 0.15 gm/24 h): was
assayed by turbidimetry (1 cc of urine + 3 cc of tri-
chloroacetic acid) where turbidity is compared to a
standard for detection of macroalbuminuria.
– Creatinine clearance (n: 80–120 ml/min): was calcu-
lated using the following equation, where Cx is cre-
atinine clearance, Px is the plasma concentration
of the creatinine, Ux is the urinary concentration
of creatinine andV is the urine ﬂow rate. It is consid-
ered as a measure of glomerular ﬁltration rate.
Cx ¼ Ux V
px
– Urinary albumin/creatinine ratio: was assayed by
Nephelometry BN ProSpec by kits purchased
from Siemens HealthCare Diagnostic Products
GmbH. Emil-Von-Behring-Str.76.35041 Marburg/
Germany, in random spot urine samples. Normal:
up to 30 lg/mg creatinine, microalbuminuria: 30–
300 lg/mg creatinine and gross proteinuria (mac-
roalbuminuria) >300 lg/mg creatinine).
(F) Radiological investigations (plain X-ray of the hands
and chest and High resolution CT-chest).– Concerning treatment, corticosteroids were received by
32 (80%) patients (2.5–50 mg/day). Fourteen patients
received IV methylprednisone with a cumulative dose
ranging from 1–6.5 gm. Methotrexate was received by
22 (55%) patient (7.5–25 mg/week). Thirteen (32.5%)
patients received IV cyclophosphamide with a cumula-
tive dose ranging from 3.6–12.6 gm. Eight (20%)
patients received azathioprine (100 mg/day). Vasodila-
tors were received by 25 (62.5%) patients.
3. Statistical analysis
All statistical calculations were done using computer programs
Microsoft Excel 2007 (Microsoft Corporation, NY, USA) and
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, USA) version 15 for Microsoft Windows. Data were
statistically described in terms of range, mean ± SD, median,
frequencies and percentages when appropriate. Comparison of
quantitative variables between the study groups was done
using Mann Whitney U test for independent samples when
comparing 2 groups and Kruskal Wallis analysis of variance
(ANOVA) test with Mann Whitney U test for independent
samples as posthoc multiple 2-group comparisons when com-
paring more than 2 groups. Correlation between various vari-
ables was done using Spearman rank correlation equation for
non normal variables. p value <0.05 was considered statisti-
cally signiﬁcant.4. Results
The clinical features and laboratory parameters of the study
SSc group are shown in Tables 1 and 2.
Complete urine analysis revealed within normal results,
none of patients had macroalbuminuria in 24 h urine analysis.
Eight (20%) patients had microalbuminuria; 4 (50%) had
dSSc, 2 (25%) lSSc and 2 (25%) SSc sine scleroderma patients.
Nine (22.5%) patients had decreased creatinine clearance.
ANAs positivity was detected in 35 (87.5%) patients.
Twenty-four (68.6%) showed speckled, 7 (20%) nucleolar and
4 (11.4%) homogenous pattern. In addition, ﬁve (62.5%) out
of eight patients with microalbuminuria showed speckled pat-
tern and 3 (37.5%) showed nucleolar pattern.
No signiﬁcant correlation was found between albumin/cre-
atinine ratio and demographic (age, sex and disease duration)
features. Albumin/creatinine ratio was signiﬁcantly higher
among dSSc patients compared to those with lSSc and SSc sine
scleroderma (Pearson’s X2 = 9.077 and p= 0.01), as shown in
Fig. 1. Furthermore, albumin/creatinine ratio showed signiﬁ-
cant positive correlations with telangiectasia and mRodnan’s
skin score (r= 0.322, 0.352 and p= 0.04, 0.026, respectively).
Albumin/creatinine ratio had signiﬁcant negative correlations
with inter-incisor distance and pleurisy (r= 0.525, 0.446
and p= 0.001, 0.004, respectively).
SSc patients with and without microalbuminuria were com-
pared regarding the various demographic and clinical features.
There was a signiﬁcant difference concerning the disease subset
(Pearson’s X2 = 7.067 and p= 0.029), 50% of patients with
microalbuminuria had dSSc, 25% had lSSc and 25% had
Table 1 Clinical features of the study SSc group.
Clinical feature Number of patients (%)
Vascular manifestations
Raynaud’s phenomenon 39 (97.5%)
Digital pitting scars 30 (75%)
Digital gangrene 6 (15%)
Bone resorption 13 (32.5%)
Calcinosis 10 (25%)
Telangiectasia 10 (25%)
GIT manifestations
Esophageal dysmotility 37 (92.5%)
Flatulence 12 (30%)
Malabsorption 13 (32.5%)
Pulmonary manifestations
Pleurisy 6 (15%)
Pleural eﬀusion 1 (2.5%)
Interstitial pulmonary ﬁbrosis 22 (55%)
Musculoskeletal manifestations
Myositis 9 (22.5%)
Myopathy 1 (2.5%)
Arthritis 14 (35%)
Neurological manifestations
CT syndrome 1 (2.5%)
Peripheral neuropathy (sensory type) 4 (10%)
Cranial nerve involvement 1 (2.5%)
Sicca manifestations 19 (47.5%)
Range (mean ± SD)
Modiﬁed Rodnan’s skin score 0–41 (16.53 ± 10.13)
Interincisor distance (cm) 1–5 (3.07 ± 1.002)
Finger to palm (in ﬂexion) distance (cm) 0–9 (1.82 ± 1.69)
Indices of SAQ
IMSS 0.00–2.25 (0.6 ± 0.68)
IVS 0.00–2.25 (1.2 ± 0.61)
IRS 0.0–2 (0.45 ± 0.48)
IGS 0.0–2.8 (0.88 ± 0.69)
IDS 0.0–2 (0.72 ± 0.49)
SAQ: Scleroderma Assessment Questionnaire; IMSS: index of
musculoskeletal status; IVS: index of vascular status; IRS: index of
respiratory status; IGS: index of gastrointestinal status; IDS: index
of disease status.
Table 2 Laboratory parameters of the study SSc group.
Laboratory parameter Range (mean ± SD)
ESR (mm/1st hour) 7–110 (39.68 ± 26.26)
Hemoglobin (gm/dl) 9.0–16.1 (12.14 ± 1.53)
WBCs count (1000/cm3) 3.6–20.1 (8.05 ± 3.35)
Platelet count (1000/cm3) 169–605 (324.45 ± 99.25)
AST (U/l) 8–125 (29.85 ± 25.25)
ALT (U/l) 6–327 (29.58 ± 52.03)
CPK (U/l) 16–2282 (253.58 ± 486.84)
LDH (U/l) 142–2,08 (471.9 ± 358.301)
Serum creatinine (mg/dl) 0.3–1.0 (0.58 ± 0.18)
Creatinine clearance (ml/min) 45–166 (102.68 ± 30.13)
Albumin/creatinine ratio (lg/mg) 4.7–72.4 (18.81 ± 14.59)
Microalbuminuria (lg/mg creatinine) 32–72.4 (43.78 + 12.94)
ESR: erythrocyte sedimentation rate; WBCs: white blood cells;
AST: aspartate transaminase; ALT: alanine transaminase; CPK:
creatinine phosphokinase; LDH: lactate dehydrogenase.
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prevalent among patients with microalbuminuria (62.5%)compared to those without (25%) (Pearson’s X2 = 4.103 and
p= 0.04).
No signiﬁcant correlations were found when albumin/creat-
inine ratio was correlated to the different laboratory parame-
ters. The comparison between SSc patients with and without
microalbuminuria regarding the different laboratory parame-
ters revealed no signiﬁcant difference as well.
Albumin/creatinine ratio correlated signiﬁcantly and posi-
tively with IMSS and IDS indices of SAQ (r= 0.378, 0.32
and p= 0.016, 0.044, respectively), as shown in Table 3. This
was further conﬁrmed by the ﬁnding that SSc patients with
microalbuminuria showed signiﬁcantly higher mean IDS than
those without (1.058 vs. 0.631, respectively and p= 0.04), as
shown in Fig. 2.
We failed to ﬁnd a statistically signiﬁcant correlation
between creatinine clearance and the different demographic
and clinical features. SSc patients with normal and those with
abnormal creatinine clearance were compared concerning the
different demographic and clinical features. Neurological man-
ifestations were signiﬁcantly more common among patients
with abnormal (33.3%) compared to those with normal creat-
inine clearance (6.5%) (Pearson’s X2 = 4.61and p= 0.03).
The comparisons between creatinine clearance and the dif-
ferent laboratory parameters could not reveal any statistically
signiﬁcant correlation. Apart from the signiﬁcant difference in
themean TLC between SSc patients with normal and those with
abnormal creatinine clearance, the comparisons concerning the
different laboratory parameters failed to reveal any signiﬁcant
difference. SSc patients with impaired creatinine clearance had
lower mean TLC compared to those with normal creatinine
clearance (5.864/cm3 vs. 8.684/cm3 and p= 0.013).
There was no signiﬁcant correlation between creatinine
clearance and the different indices of the SAQ. Moreover,
the comparison between SSc patients with normal creatinine
clearance and those with abnormal creatinine clearance
regarding the different indices of the SAQ could not reveal
any signiﬁcant difference.5. Discussion
The kidney is one of the most clearly affected internal organs
that show the complications of vascular insult in SSc [14].
Autopsy studies reveal histological evidence of renal
involvement in 60–80% of patients with SSc [15]. In addition,
clinical evidence of mild renal involvement including; mild pro-
teinuria, elevated serum creatinine concentration or hyperten-
sion, has been detected in 50% of patients [16]. In contrast to
the common mild renal dysfunction, scleroderma renal crisis is
considered less frequent [14].
Owing to the cumbersome collection of 24 h urine volume
and the inaccuracy of the result obtained by the dip stick meth-
od as a consequence of the variation of urinary protein concen-
tration according to the urinary volume [17], estimation of
albumin/creatinine ratio (lg/mg) on a urine sample is used
to accurately measure urinary protein excretion [18]. More-
over, microalbuminuria can detect early renal disease before
progression of the condition to structural renal damage and
frank macroalbuminuria [19].
Eight (20%) of our SSc patients had microalbuminuria.
This coincides with the data demonstrated in the literature
where microalbuminuria was detected in 17.9%, 19.04% and
Figure 1 The comparison between patients with dSSc and those with lSSc and SSc sine scleroderma regarding albumin/creatinine ratio.
Table 3 The correlation between albumin/creatinine ratio and
the different indices of SAQ.
Indices of SAQ r p Value
IMSS 0.378 0.016
IVS 0.039 0.811
IRS 0.244 0.129
IGS 0.201 0.213
IDS 0.320 0.044
IMSS: index of musculoskeletal status; IVS: index of vascular sta-
tus; IRS: index of respiratory status; IGS: index of gastrointestinal
status; IDS: index of disease status.
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concomitant hypertension and diabetes mellitus [4,15,20].
In disagreement with Seiberlich et al. [4] who found that al-
most half (45.5%) of SSc patients who had albuminuria in
their study were males, we found no signiﬁcant correlation be-
tween the presence of microalbuminuria and gender.
In the present work, albumin/creatinine ratio was not re-
lated to patient’s age or the disease duration, coinciding with
the results of Dawnay et al. [20]. On the contrary, SeiberlichFigure 2 The correlation between aet al. reported that albuminuria was signiﬁcantly more preva-
lent in SSc patients whose disease duration was >4 years [4].
In agreement with Seiberlich et al. [4] who found that albu-
minuria was more prevalent among diffuse subtype, in the cur-
rent study, albumin/creatinine ratio was signiﬁcantly higher
among dSSc patients compared to those with lSSc and SSc sine
scleroderma. Furthermore, we found that albumin/creatinine
ratio increases signiﬁcantly with higher modiﬁed Rodnan’s
skin score and decreased interincisor distance. This coincides
with the results of El Sayed et al. who also revealed that
patients with microalbuminuria had more extensive skin dis-
ease [21].
There was a signiﬁcant positive correlation between albu-
min/creatinine ratio and the presence of telangiectasia which
can emphasize the association between renal affection and vas-
culopathy in SSc. In this context, Mohamed et al. detected sig-
niﬁcant negative correlation between measured GFR and
pulmonary hypertension suggesting that SSc patients with
PAH are at a greater risk of developing renal involvement
[22]. Campo et al. reported strong association between pul-
monary hypertension and renal dysfunction [23]. Furthermore,
the presence of ANA centromeric pattern, vasculopathy and
decreased GFR had been found to be associated [24,25].lbumin/creatinine ratio and IDS.
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patients with pulmonary involvement [4] and that patients with
pulmonary ﬁbrosis were more susceptible to have microalbu-
minuria [21]. On the other hand, we didn’t ﬁnd a signiﬁcant cor-
relation between albumin/creatinine ratio and pulmonary
manifestations except for a negative correlation with pleurisy.
This may be explained by the fact that patients with both inter-
stitial lung disease and pulmonary hypertension were included
in the former studies and those with pulmonary hypertension
were excluded from our study. Moreover, the negative correla-
tion with pleurisy could be explained by the different patholog-
ical processes implicated in the pathogenesis of either of both
parameter, i.e., inﬂammatory process in pleural affection and
vascular and ﬁbrotic processes in microalbuminuria.
In this study, malabsorption was more common in SSc
patients with microalbuminuria. In agreement, it was revealed
that patients with gastrointestinal involvement were at a higher
risk of developing albuminuria [4] and hypovolemia secondary
to gastrointestinal involvement may also contribute to renal
affection in SSc patients [16].
In disagreement with El Sayed et al. [21] who detected a sig-
niﬁcant positive correlation between the degree of microalbu-
minuria and serum creatinine level, we could not ﬁnd a
correlation between albumin/creatinine ratio and serum creat-
inine level. This discrepancy between the studies could be ex-
plained by the different characteristics of enrolled SSc
patients as 50% of patients in the former study had low base-
line GFR. This may highlight the role of microalbuminuria as
an early indicator of renal affection before impairment of
GFR. In support to our ﬁnding, Dawnay et al. demonstrated
the value of increased albumin excretion in SSc patients as
an indicator of underlying vascular pathology that may also
herald the onset of renal disease [20].
Moreover, albumin/creatinine ratio increased signiﬁcantly
with higher IMSS and IDS of SAQ indices and SSc patients
with microalbuminuria had signiﬁcantly higher mean value
of IDS compared to those patients without microalbuminuria.
In contrast, there was neither a signiﬁcant correlation between
creatinine clearance and the different indices of the SAQ nor a
signiﬁcant difference between SSc patients with normal and
those with abnormal creatinine clearance regarding the differ-
ent indices of the SAQ. This suggests that microalbuminuria
may be a predictor of increased morbidity and disease severity
rather than just a marker of renal affection.
No signiﬁcant difference was found between SSc patients
with normal and those with abnormal creatinine clearance
regarding the different demographic and clinical features
except that regarding neurological manifestations which were
more prevalent among those with impaired creatinine clear-
ance. The increased prevalence of neurological manifestations
among patients with impaired creatinine clearance could be
explained by the increased disease severity which is reﬂected
on both the neurological and renal systems. Several studies
in the literature had revealed no correlation between creatinine
clearance and any of disease subset, patient’s age, interstitial
lung disease, gastrointestinal tract involvement, modiﬁed
Rodnan’s skin score and muscle affection [22,26,27].
Other causes apart from renal disease can affect creati-
nine clearance as evidenced by the reduction of baseline
GFR in normal individuals with low protein diet [28,29].
The reduction of GFR in our SSc patients without microal-
buminuria may be explained by decreased protein intakeand/or decreased renal perfusion secondary to gastrointesti-
nal tract involvement with the subsequent reduction of pro-
tein and ﬂuid intake.
We can conclude that the evaluation of microalbuminuria
compared to creatinine clearance may be a more sensitive indi-
cator of early renal affection in SSc patients with the additional
advantage of being a predictor of systemic vasculopathy and in-
creased morbidity of the different organs systems. Subse-
quently, regular screening of SSc patients for the detection of
microalbuminuria is recommended. Microalbuminuric patients
should have more frequent follow up visits for early detection
systemic organ affection.Conﬂict of interest statement
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